Hormone receptor positive breast tumor

A hormone-receptor-positive (HR+) tumor is a tumor which consists of cells that express receptors for certain hormones. The term most commonly refers to estrogen receptor positive estrogen receptor positive tumors  (i.e. tumors that contain estrogen receptor positive cells), but can also include progesterone receptor positive tumors. Estrogen-receptor-positive tumors depend on the presence of estrogen for ongoing proliferation.

 

 

  • Lowering systemic levels of estrogen.
  • Achieved by the use of drugs from the aromatase inhibitor category.
  • Blockage of the estrogen receptors on the cancerous cells
  • Treating hematological malignancies such as lymphoma and leukemia (cancers)
  • The science of blood transfusion and the work of a blood bank

Related Conference of Hormone receptor positive breast tumor

April 16-17, 2025

9th International Conference on Internal Medicine

Berlin, Germany
May 12-13, 2025

19th International Conference on Obesity Medicine

Toronto, Canada
June 24-25, 2025

3rd Global Summit on HIV-AIDS and STDs

Chicago, USA
July 21-22, 2025

24th International Conference on Genomics and Molecular Biology

Aix-en-Provence, France
August 07-08, 2025

12th World Summit on Epilepsy and Bipolar Disorders

Paris, France
August 14-15, 2025

20th International Conference on Clinical & Medical Case Reports

Aix-en-Provence, France
August 25-26, 2025

8th International Conference on Community Nursing and Public Health

Singapore City, Singapore
September 22-23, 2025

39th International Conference on Cancer Science & Therapy

Amsterdam, Netherlands
September 22-23, 2025

17th Annual Congress on Drug Formulation & Analytical Techniques

Amsterdam, Netherlands
October 16-17, 2025

19th International Conference on Pathology and Laboratory Medicine

Aix-en-Provence, France
November 03-04, 2025

5th World Medicine Congress

Rome, Italy

Hormone receptor positive breast tumor Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in